|
WO2020028508A1
|
|
Solid oral formulations of amphotericin b
|
|
US2020155583A1
|
|
Solid oral formulations of amphotericin b
|
|
US2018000854A1
|
|
Stable formulations for the oral administration of amphotericin b and related methods
|
|
WO2011112516A1
|
|
Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides
|
|
US2013028889A1
|
|
Dosing regimens for treating and preventing ocular disorders using c-raf antisense
|
|
US2007275029A1
|
|
Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders
|
